Breaking News

Sernova Teams Up With CCRM

Will produce specialized cells for the treatment of diabetes

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sernova has entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to establish, optimize and validate Sernova’s licensed technology for creating stem cell derived therapeutic cells that produce insulin and are glucose responsive. Sernova’s Cell Pouch System is a novel, preclinically validated and clinically tested platform for multiple types of therapeutic cells, including human islets. “Sernova’s CCRM partnership with CCRM’s expertise in devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters